Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Revue Des Maladies Respiratoires
|
April 1, 1997
[Pulmonary and musculo-cutaneous thigh actinomycosis]
L Falchero, F Philit, F Berger, et al.
Presse Medicale (Paris, France : 1983)
|
June 15, 1999
[Carcinomatous lymphangitis]
S Hominal, L Falchero, M Perol, et al.
Revue Des Maladies Respiratoires
|
July 25, 1998
[Spontaneous resolution of multiorgan sarcoidosis associated with malignant lymphoma]
L Falchero, P Nesme, M Perol, et al.
Revue Des Maladies Respiratoires
|
June 9, 2016
[Bevacizumab in combination with first-line treatment for metastatic non-small cell lung cancer in clinical practice. Results of the EOLE study]
C Chouaid, L Falchero, R Schott, et al.
Bulletin Du Cancer
|
November 1, 1996
[Malignant mesothelioma of the pleura following radiotherapy of Hodgkin disease]
L Falchero, B Coiffier, B Guibert, et al.
The European Respiratory Journal
|
June 3, 2008
Respiratory failure with diffuse bronchiectases and cryoglobulinaemia
N Girard, A Vasiljevic, V Cottin, et al.
Journal of Mass Spectrometry : JMS
|
May 24, 2018
Rapid and noninvasive quality control of anhydrous milk fat by PTR-MS: The effect of storage time and packaging
M Pedrotti, I Khomenko, L Cappellin, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 13, 2012
A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)
H LeCaer, L Greillier, R Corre, et al.
Food & Function
|
January 4, 2021
Effect of industrial processing and storage procedures on oxysterols in milk and milk products
D Risso, V Leoni, C Fania, et al.
British Journal of Cancer
|
September 22, 2011
A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study)
H LeCaer, F Barlesi, R Corre, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Revue Des Maladies Respiratoires
|
April 1, 1997
[Pulmonary and musculo-cutaneous thigh actinomycosis]
L Falchero, F Philit, F Berger, et al.
Presse Medicale (Paris, France : 1983)
|
June 15, 1999
[Carcinomatous lymphangitis]
S Hominal, L Falchero, M Perol, et al.
Revue Des Maladies Respiratoires
|
July 25, 1998
[Spontaneous resolution of multiorgan sarcoidosis associated with malignant lymphoma]
L Falchero, P Nesme, M Perol, et al.
Revue Des Maladies Respiratoires
|
June 9, 2016
[Bevacizumab in combination with first-line treatment for metastatic non-small cell lung cancer in clinical practice. Results of the EOLE study]
C Chouaid, L Falchero, R Schott, et al.
Bulletin Du Cancer
|
November 1, 1996
[Malignant mesothelioma of the pleura following radiotherapy of Hodgkin disease]
L Falchero, B Coiffier, B Guibert, et al.
The European Respiratory Journal
|
June 3, 2008
Respiratory failure with diffuse bronchiectases and cryoglobulinaemia
N Girard, A Vasiljevic, V Cottin, et al.
Journal of Mass Spectrometry : JMS
|
May 24, 2018
Rapid and noninvasive quality control of anhydrous milk fat by PTR-MS: The effect of storage time and packaging
M Pedrotti, I Khomenko, L Cappellin, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 13, 2012
A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)
H LeCaer, L Greillier, R Corre, et al.
Food & Function
|
January 4, 2021
Effect of industrial processing and storage procedures on oxysterols in milk and milk products
D Risso, V Leoni, C Fania, et al.
British Journal of Cancer
|
September 22, 2011
A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study)
H LeCaer, F Barlesi, R Corre, et al.
Page
of 2